Durvalumab vs Pregabalin

Durvalumab vs Pregabalin: Overview

This comparison examines the pharmacological differences between Durvalumab and Pregabalin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pregabalin: Binds alpha-2-delta subunit of voltage-gated calcium channels.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Pregabalin — 6.3 hours.

Chemical Properties

Molecular Formula: Pregabalin — C8H17NO2.

Molecular Weight: Pregabalin — 159.2260 g/mol.

Type: Durvalumab — Antibody; Pregabalin — Small molecule.